en
Scientific article
English

Birth defects after exposure to efavirenz-based antiretroviral therapy at conception/first trimester of pregnancy: a multicohort analysis

ContributorsMartinez De Tejada Weber, Begona; Gayet-Ageron, Angèle; Winterfeld, Ursula; Thorne, Claire; Favarato, Graziella; European Pregnancy and Paediatric HIV Cohort Collaboration Study Group
Published inJournal of Acquired Immune Deficiency Syndromes, vol. 80, no. 3, p. 316-324
Publication date2019
Abstract

To investigate the association between efavirenz (EFV) use during conception or first trimester (T1) of pregnancy and the occurrence of birth defects.

Keywords
  • Abnormalities
  • Drug-Induced
  • Abortion
  • Spontaneous
  • Anti-HIV Agents/adverse effects/therapeutic use
  • Benzoxazines/adverse effects/therapeutic use
  • Cohort Studies
  • Female
  • Fertilization
  • HIV Infections/drug therapy
  • Humans
  • Infant
  • Newborn
  • Pregnancy
  • Pregnancy Complications
  • Infectious/drug therapy
  • Pregnancy Trimester
  • First
  • Stillbirth
Citation (ISO format)
MARTINEZ DE TEJADA WEBER, Begona et al. Birth defects after exposure to efavirenz-based antiretroviral therapy at conception/first trimester of pregnancy: a multicohort analysis. In: Journal of Acquired Immune Deficiency Syndromes, 2019, vol. 80, n° 3, p. 316–324. doi: 10.1097/QAI.0000000000001922
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Identifiers
ISSN of the journal1525-4135
169views
1downloads

Technical informations

Creation08/17/2020 2:14:00 PM
First validation08/17/2020 2:14:00 PM
Update time03/15/2023 10:47:33 PM
Status update03/15/2023 10:47:32 PM
Last indexation01/17/2024 11:09:18 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack